illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Probi
Company logo

Probi | Sustainability Performance

https://www.probi.com

Probi AB specializes in developing probiotics and dietary supplements, aiming to promote health and wellness through innovative solutions targeted at various consumer needs.

2005

Sweden

51 - 200 employees

Biotechnology

$25M - 100M in revenue

$1M - 10M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#1894
Overallⓘ
#145
in Swedenⓘ
#27
in Biotechnologyⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

21 out of 243

Overview
Environmental
Carbon certificatesDigital emissionsEnergy consumption
Governance
Targets
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Cantargia

Sweden, Health Care, Biotechnology


Company logo
Hansa Biopharma

Sweden, Health Care, Biotechnology


Company logo
Immunovia

Sweden, Health Care, Biotechnology

Renewable energy ⓘProportion of the company's total electricity consumption sourced from renewable sources, expressed as a percentage.
100%2023
Leading
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
627.0M$, 2023▼1.4% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
5.74%2023

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Probi's probiotic health claims faced regulatory challenges in the EU where health claim approvals for probiotics remain restrictive.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

2-3

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.


    Available in
    Scale package

    Access
  • Email

  • Email